| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |